That's great. Thank you very much for that.
I have a couple of questions for Mr. Warner. It's good to see you back at our committee.
I want to touch on the proposed TRIPS waiver. In past meetings of this committee, we have heard from some experts on the importance of quality control in the production of vaccines and about how this waiver may reduce that ability. Would you agree with that assertion? Do you have any comments on that?